Community Q&A

Retatrutide Skin Sensitivity: Why Injections Can Hurt More

A community member on retatrutide asked why their skin got so sensitive the needle hurt, and why their belly fat feels different. Here is what the trial data and injection research say.

Last reviewed November 18, 2026 5 min read By Dave Belmonte, Founder
RetatrutideSide EffectsInjection SiteCommunity Q&A
More peptide questions answered

Educational only, not medical advice: Retatrutide is an investigational drug from Eli Lilly and is not FDA-approved. Nothing here is a personal plan or dosing advice. Talk to a qualified healthcare provider, ideally whoever oversees your use, about any side effect.

Asked in the community

"I'm on reta and my skin has gotten so sensitive that even the needle hurt badly when I tried a new spot, so I didn't inject. And the fat on my belly feels weird now, not like fat anywhere else. Is that just the fat breaking down?"

Short Answer

Skin sensitivity is a documented retatrutide side effect: in Lilly's TRIUMPH-4 trial, dysesthesia (burning, tingling or sore skin) was reported by 8.8% of people on 9 mg and 20.9% on 12 mg, compared with 0.7% on placebo, and was generally mild. Sensitive skin can make injections feel worse. A belly that feels firm, rubbery or lumpy is more often a sign of repeated injections in the same area than of fat breaking down, so rotating sites matters.

Skin Sensitivity Is a Known Retatrutide Side Effect

Retatrutide activates three hormone receptors (GIP, GLP-1 and glucagon), where semaglutide activates one and tirzepatide two. In Eli Lilly's announcement of TRIUMPH-4, its first Phase 3 trial, dysesthesia occurred in 8.8% of patients on 9 mg and 20.9% on 12 mg, compared to 0.7% on placebo. Lilly described the events as generally mild and said they rarely led to people stopping treatment.

Source: Eli Lilly and Company. "Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Press release, December 11, 2025. investor.lilly.com

Dysesthesia means an unpleasant, abnormal sense of touch: skin that burns, tingles or feels sore when nothing has injured it. Detailed TRIUMPH-4 results had not been published in a peer-reviewed journal at the time of Lilly's announcement. The earlier Phase 2 trial, published in 2023, established retatrutide's weight-loss effect in 338 adults with obesity. See Retatrutide Human Studies for the full trial history.

Research reference: Jastreboff AM, Kaplan LM, Frías JP, et al. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial." New England Journal of Medicine. 2023. PMID: 37366315

Why Injections Can Hurt More on Retatrutide

No study has directly measured injection pain in people with retatrutide-related dysesthesia. Still, it is reasonable that skin which already burns or feels sore to the touch would make a needle, or a peptide that stings on its own like the GHK-Cu in KLOW, feel worse. If an area is too sensitive to inject comfortably, skipping it and using another site is a sensible call.

Why Belly Fat Can Feel Different

Two things can change how an injection area feels. Losing a lot of weight thins the fat layer, so the area can feel different from before. Separately, injecting into the same area over and over can cause lipohypertrophy: a firm, rubbery or lumpy thickening of the fat under the skin. It is well studied in people who inject insulin, and in a study of 430 insulin users the researchers concluded that correct injection site rotation appears to be the critical factor in preventing it. Injecting into these areas can hurt more and may absorb less evenly. It is not a sign that the fat is breaking down.

Research reference: Blanco M, Hernández MT, Strauss KW, Amaya M. "Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes." Diabetes & Metabolism. 2013. PMID: 23886784

What People Commonly Try

  • Rotate sites widely across the abdomen, thighs and other common areas instead of using one spot. The injection site rotation guide shows the usual areas.
  • Skip areas that feel firm, lumpy or extra sensitive and give them time to settle.
  • Tell whoever oversees your retatrutide if skin sensitivity keeps going or gets worse.

When to See a Doctor

Talk to a clinician if burning, tingling or skin sensitivity does not settle or is getting worse, or if you notice numbness or weakness. For an injection site itself:

Get it checked by a doctor if you notice any of these:

  • Redness that keeps spreading, or red streaks moving away from the spot
  • Heat, swelling that keeps growing, or a hard, painful lump
  • Pus or drainage, or a fever or chills
  • Pain that is getting worse after a day or two instead of fading

These can be signs of an infection or abscess, which is not something to wait out.

See Retatrutide for how the drug works, Retatrutide Human Studies for the trial data, and Retatrutide vs Tirzepatide for how it compares. If injections sting for another reason, read why KLOW can burn hours later, or browse more peptide questions answered.

Have a question of your own?

Ask it in the BioStackIQ community. Good questions get a full, sourced answer like this one.

Ask a question

Frequently Asked Questions

Does retatrutide cause skin sensitivity?

Yes, it is a documented side effect. In Eli Lilly's Phase 3 TRIUMPH-4 trial, dysesthesia (burning, tingling or sore skin) occurred in 8.8% of patients on 9 mg and 20.9% on 12 mg, compared to 0.7% on placebo. Lilly said the events were generally mild and rarely led to people stopping treatment.

What is dysesthesia?

Dysesthesia is an unpleasant, abnormal sense of touch, such as skin that burns, tingles or feels sore when nothing has injured it. It was reported as a side effect of retatrutide at higher doses in Phase 3 trials.

Why does my belly fat feel weird where I inject?

Injecting into the same area repeatedly can cause lipohypertrophy, a firm, rubbery or lumpy thickening of the fat under the skin. In research on insulin users, correct injection site rotation was the key factor in preventing it. Weight loss can also thin the fat layer. A firm or lumpy area is not a sign that fat is breaking down.

Is retatrutide FDA-approved?

No. Retatrutide is an investigational drug from Eli Lilly that is still in Phase 3 trials and is not FDA-approved.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Retatrutide is an investigational drug and is not FDA-approved. Always consult a qualified healthcare provider before starting any peptide protocol.